Asan Multivessel Registry
ConditionCoronary Artery Disease
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age19+
SponsorSeung-Jung Park
About this trial
The purpose of this study is to evaluate long-term prognoses of patients with multivessel coronary disease treated medically or surgically or percutaneously in real world practice.
Eligibility criteria
Qualifiers
Patients with multivessel disease from 1995 in Asan Medical Center
Age 19 and more
Disqualifiers
For prospective cohort, not agreeing to participate with written informed consent form
Trial design
Treatments tested in this trial
- Treatment
Treatment groups
25,000 Participants
are divided into 1 treatment groupSponsors and collaborators
Seung-Jung Park
Lead sponsor
Asan Medical Center
Sponsor institution
CardioVascular Research Foundation, Korea
Collaborator
Source ClinicalTrials.gov